Breaking News, Collaborations & Alliances

MilliporeSigma and Baylor Enter COVID-19 Vax Pact

Will focus on process development and improvements for manufacturing Baylor's Covid-19 vaccine candidates

By: Contract Pharma

Contract Pharma Staff

MilliporeSigma and Baylor College of Medicine today announced an extension of their ongoing collaboration to advance a manufacturing platform to fight Covid-19, accelerating the transition to Phase 1 clinical trials.   “Vaccine manufacturing is extremely complicated, so we are collaborating on a process development approach to accelerate manufacturing of Baylor’s Covid-19 vaccine candidates,” said Udit Batra, chief executive officer, MilliporeSigma. “To fight this pandemi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters